{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-038620","form_type":"8-K","ticker":"OTLC","cik":"0000908259","company_name":"Oncotelic Therapeutics, Inc.","filed_at":"2023-10-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:32.355374+00:00","generated_at":"2026-06-09T06:29:20.608281+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Oncotelic closes 3rd tranche of unit financing, raising $1.05M via convertible notes and warrants","bullets":["42 units issued at $25,000 each for aggregate $1.05M; each unit includes a convertible note and 250,000 warrants.","Notes convertible at $0.10/share; warrants exercisable at $0.12/share; placement agent fees of $157,500 paid.","Debt of $1.05M from 27 accredited investors converted into the units under the subscription agreements.","Third tranche of a financing previously reported in July 2023; total units subject to best-efforts placement agent agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-038620","json":"https://secwatch.observer/filing/0001493152-23-038620.json","markdown":"https://secwatch.observer/filing/0001493152-23-038620.md","text":"https://secwatch.observer/filing/0001493152-23-038620.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/908259/000149315223038620/0001493152-23-038620-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/908259/000149315223038620/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T06:29:20.608281+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}